Bernard Kasten

Directeur Général chez GENELINK, INC.

Profil

Bernard L.
Kasten is currently the Executive Chairman, President & CEO at GeneLink, Inc. He is also the Chairman at Riggs Heinrich Media, Inc., Director at CytoLogic, Inc., Director at Wolters Kluwer Clinical Drug Information, Inc., Director at PIPO, Inc., Director at Highway Composites LLC, and Director at Monroeville Industrial Molding, Inc. Previously, Dr. Kasten served as the Chairman-Internet Editorial Board at the College of American Pathologists from 1985 to 2003.
He was also the Lead Independent Director at Enzo Biochem, Inc. from 2008 to 2017, Director at SIGA Technologies, Inc. from 2003 to 2006, Director at SeraCare Life Sciences, Inc., Director at Cleveland BioLabs, Inc. in 2013, Chief Laboratory Officer at Quest Diagnostics, Inc. from 1995 to 2004, and Vice President-Medical Affairs at MedPlus, Inc.Dr. Kasten obtained his undergraduate degree from Miami University in 1967 and his doctorate degree from The Ohio State University College of Medicine in 1971.

Postes actifs de Bernard Kasten

Sociétés	Poste	Début
GENELINK, INC.	Directeur Général	15/11/2013
Wolters Kluwer Clinical Drug Information, Inc.	Directeur/Membre du Conseil	-
Riggs Heinrich Media, Inc.	Président	-
CytoLogic, Inc.	Directeur/Membre du Conseil	30/12/2009
Highway Composites LLC	Directeur/Membre du Conseil	30/12/2009
Monroeville Industrial Molding, Inc.	Directeur/Membre du Conseil	30/12/2009
PIPO, Inc.	Directeur/Membre du Conseil	30/12/2009

Anciens postes connus de Bernard Kasten

Sociétés	Poste	Fin
ENZO BIOCHEM, INC.	Directeur/Membre du Conseil	05/01/2017
STATERA BIOPHARMA, INC.	Président	25/04/2013
░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░